학술논문
P216 - Neutrophil-to-eosinophil ratio (NER) predicts the efficacy of avelumab in patients with advanced Urothelial Carcinoma (aUC) enrolled in the MALVA study (Meet-URO 25)
Document Type
Abstract
Author
Source
In European Urology Open Science November 2023 57 Supplement 1:S301-S302
Subject
Language
ISSN
2666-1683